XTL Biopharmaceuticals Ltd.XTL Biopharmaceuticals Ltd.XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd.

No trades
Buy XTLB
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪20.95 M‬USD
−0.07USD
‪−1.78 M‬USD
‪12.23 M‬
Beta (1Y)
2.55

About XTL BIO


CEO
Shlomo Spokone Shalev
Website
Headquarters
Ramat Gan
Founded
1993
FIGI
BBG000F1JVP4
XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its product pipeline includes hCDR1 and rHuEPO. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.